(Q46943513)

26 December 2017

title

Association of p53 codon 72 polymorphism with risk of hypopharyngeal squamous cell carcinoma in Taiwan (English)

1 reference

26 December 2017

hypopharyngeal squamous cell carcinoma

main subject

0 references

author name string

Chih-Wen Twu

1

1 reference

26 December 2017

Rong-San Jiang

2

1 reference

26 December 2017

Chih-Hung Shu

3

1 reference

26 December 2017

Jin-Ching Lin

4

1 reference

26 December 2017

publication date

1 February 2006

1 reference

26 December 2017

Journal of the Formosan Medical Association

published in

1 reference

26 December 2017

volume

105

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

99-104

1 reference

26 December 2017

Hypopharyngeal cancer patient care evaluation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

Primary structure polymorphism at amino acid residue 72 of human p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

Role of a p53 polymorphism in the development of human papillomavirus-associated cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

Codon 72 polymorphism of p53 and its association with cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

p53 codon 72 polymorphism and risk of cervical cancer in UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

p53 and genetic susceptibility to cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

Distributions of p53 codon 72 polymorphism in bladder cancer--proline form is prominent in invasive tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

p53 codon 72 polymorphism and its association with bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

P53 codon 72 polymorphism in bladder cancer--no evidence of association with increased risk or invasiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

Association of codon 72 polymorphism of p53 with lower prostate cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

Genetic Polymorphism inp53Codon 72 and Skin Cancer in Southwestern Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

p53 codon 72 polymorphism and human papillomavirus associated skin cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

Genetic polymorphisms of p53 and GSTP1,but not NAT2,are associated with susceptibility to squamous-cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

p53 codon 72 polymorphism as a risk factor in the development of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

p53 polymorphisms and haplotypes in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

No association between P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

Genetic polymorphisms in head and neck cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

The complexity of p53 modulation: emerging patterns from divergent signals

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

p53 function and dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

Identification of a novel p53 functional domain that is necessary for efficient growth suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

The polyproline region of p53 is required to activate apoptosis but not growth arrest.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

Two polymorphic variants of wild-type p53 differ biochemically and biologically

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

A common polymorphism acts as an intragenic modifier of mutant p53 behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

Determination of p53 genotypes in oral cancer patients from India

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

p53 Codon 72 polymorphism is linked to the development and not the progression of benign and malignant laryngeal tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

Is p53 polymorphism maintained by natural selection?

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960330-2

7 January 2021

10.1016/S0929-6646(09)60330-2

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017